Crossmark

Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001–2022

Crossref DOI link: https://doi.org/10.1007/s10096-025-05114-8

Published Online: 2025-05-02

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fletcher, Mark A.

Okasha, Omar

Baay, Marc

Syrochkina, Maria

Hayford, Kyla
License Information

Text and Data Mining valid from 2025-05-02

Version of Record valid from 2025-05-02
More Information

Article History

Received: 30 October 2024

Accepted: 20 March 2025

First Online: 2 May 2025

Declarations

:

: MAF, MS, and KH are employees of Pfizer and may hold stock or stock options. OO and MB are employees of P95 Clinical & Epidemiology Services, which received funding from Pfizer in connection with the development of this manuscript and the execution of this study.

Document is current

Any future updates will be listed below